Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Payables (2023 - 2025)

Metagenomi (MGX) has disclosed Payables for 3 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Payables rose 179.36% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2025, up 179.36% year-over-year, with the annual reading at $1.5 million for FY2025, 179.36% up from the prior year.
  • Payables for Q4 2025 was $1.5 million at Metagenomi, up from $1.2 million in the prior quarter.
  • The five-year high for Payables was $6.8 million in Q1 2024, with the low at $533000.0 in Q4 2024.
  • Average Payables over 3 years is $2.7 million, with a median of $2.7 million recorded in 2025.
  • The sharpest move saw Payables plummeted 70.24% in 2024, then surged 179.36% in 2025.
  • Over 3 years, Payables stood at $1.8 million in 2023, then tumbled by 70.24% to $533000.0 in 2024, then soared by 179.36% to $1.5 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $1.5 million, $1.2 million, and $2.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.